KimboCare, Top 10 startup at the 2022 McKinsey’s Early-Stage Investor Conference
New York, June 22, 2022 – KimboCare was invited to join the annual McKinsey & Company Early-Stage Investor Conference this week, presenting KimboCare and ways we bring fintech and healthtech onto one end-to-end digital platform to drive value-based care and affordable healthcare access for underserved communities in developing regions, starting with Africa.
KimboCare was amongst the Top 10 #startups selected out of the 70+ applicants to participate in the "Healthtech Track" alongside other outstanding ventures transforming the healthcare game worldwide such as Bento and Lyfegen. “We are coming out of it even more inspired as we drive transparency in healthcare access at large, one country at the time. We also enjoyed the very seasoned challenging board panel the ESIC team put together.
KimboCare enables transparency in the payment and delivery of quality medical services. Our Swiss-made technology platform enables our clients worldwide to purchase medical care in the form of Health Credits, our innovative concept, for patients with limited financial means; those patients in turn use those health credits at dedicated medical partners in developing regions. Our health credits provide clients with transparency, peace of mind and flexibility - all attributes not available with other existing solutions (remittances or insurance). With KimboCare’s end-to-end digital platform, clients support access to care as often and as reliably as they desire.
For media inquiries please contact us at [email protected].
About McKinsey’s ESIC
McKinsey & Company, a global management consulting firm, is the trusted advisor and counselor to many of the world's most influential businesses and institutions. McKinsey hosts the Early-Stage Investor Conference (ESIC) to inspire and advance innovation among a global community of start-ups, investors, researchers, and leading-edge organizations. The healthtech track covers digital health companies that are transforming patient care, with a focus on start-ups looking to improve health equity, leverage data in new ways, and expand AI-facilitated diagnostics.